Dayun Bio-Medicine* - April 2026 Revenue: 172 Million (Year-on-Year Increase of +40.5%)
NQ Score
0/100
N1 Content Completeness
0.8
AI Summary (NQ-processed)
Dayun Bio-Medicine* announced April 2026 revenue of 171.84 million yuan, achieving a significant 40.5% increase year-on-year. This growth indicates strong market performance for its food industry products.